Overview of companies on the stock market
The bank advises investors to pay attention to three characteristics in a period of high volatility. What to look for Starting in 2022, investors are shifting from expensive growth stocks to value stocks. All because, that the market fears the Fed's interest rate hike.
Some in the West refuse to buy Russian oil - but prices only grow from this. And Hapag-Lloyd expands business in Africa. Disclaimer: when we talk about, that something has grown, we mean a comparison with the same quarter a year earlier. Since all issuers are from the USA, then all results in dollars.
Gazprom Neft (MCX: SIBN) — a large vertically integrated holding, carrying out reconnaissance, development and production of oil and gas in Russia, Iraq and Serbia. Company on 95,68% owned by Gazprom, that is, in free circulation is less than 5% issuer's shares.
What western issuers can expect from the events around Russia. Google spares no money on cybersecurity. Disclaimer: when we talk about, that something has grown, we mean a comparison with the same quarter a year earlier. Since all issuers are from the USA, then all results in dollars.
The US regulator could not check the audit reports of some Chinese companies. In 2021, the SEC - the US Securities and Exchange Commission - approved a law to bring foreign companies to justice.
English visual effects studio DNEG plans to go public by merging with SPAC. We decided to disassemble the company's business, to understand, does it make sense to invest in special effects. When creating the material, sources were used, inaccessible to users from the Russian Federation. We hope, Do you know, what to do.
Today we have a moderately speculative idea.: take shares of the American industrial enterprise EnPro Industries (NYSE: NPO), in order to make money on the growth of production in the United States.
Today we have a speculative investment aide: take shares of solution provider for semiconductor production SiTime (NASDAQ: SITM), in order to make money on the growth of these shares after the fall. Growth potential and validity: 22% behind 15 Months; 59% behind 3 of the year; 11% per annum during 15 years.
Vaxart (Nasdaq: VXRT) - San Francisco, an American pharmaceutical company based in San Francisco, which develops vaccines in pill form in the early clinical stages. The issuer's shares are represented on the Nasdaq since 2015.
For 22 years since the last split, the company's shares have risen by 4500%. Split details 9 Amazon's board of directors approved the split of shares in March. If shareholders support the decision, crushing will be carried out 3 June in the ratio 20:1.